EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Iatrogenic Cerebral Amyloid Angiopathy in Patients Treated With Cadaveric Dura Mater During Childhood Neurosurgery: A Retrospective Cohort Study

Slaven Pikija, Andreea Toma, Richard Radlberger, Christoph J Griessenauer, Constantin Hecker, Eugen Trinka, Park Hyon Ki, Theo Kraus, Serge Weis, Marieke J H Wermer, Ellis S van Etten, Kanishk Kaushik

European Journal of Neurology · 2025

DOI: 10.1111/ene.70091 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Slaven Pikija und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Neurocritical Care and Neurorehabilitation, Member of the European Reference Network EpiCARE, Christian Doppler University H…. Hauptthemen laut MEDLINE: Dura Mater, Cerebral Amyloid Angiopathy, Neurosurgical Procedures, Iatrogenic Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Iatrogenic cerebral amyloid angiopathy (iCAA) is a recently identified clinico‐neuroradiological syndrome associated with medical procedures, particularly neurosurgical treatments involving cadaveric dura mater (e.g., Lyodura). iCAA can manifest as intracerebral hemorrhages, focal seizures, and cognitive impairment, with the risk following exposure currently unknown. We aim to evaluate the risk of developing iCAA in patients who underwent childhood neurosurgical treatment with Lyodura compared to those who did not.

Methods

This retrospective cohort study analyzed hospital records from the Christian‐Doppler University Hospital in Salzburg, along with mortality data provided by the Austrian Federal Institute of Statistics (Statistik Austria). The study included all patients aged 0–18 who underwent neurosurgical procedures between January 1970 and January 1996. The primary endpoint was the diagnosis of iCAA and iCAA‐related death.

Results

Of 569 pediatric neurosurgical patients, 388 (68%) were further analyzed. Four patients (1%) were diagnosed with probable iCAA at a median age of 42 years (IQR 40–47), with a median latency from surgery to symptom onset of 38 years (IQR 36–41). Only Lyodura recipients developed iCAA, with an incidence rate of 12% (OR 56, 95% CI: 6–2667). The overall incidence of symptomatic iCAA among recipients of any dura material was 5% (OR 19, 95% CI: 2–903).

Conclusions

Cadaveric dura mater, especially Lyodura, poses a long‐term risk for developing iCAA. Further research is needed to determine susceptibility factors in Lyodura‐exposed individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dura MaterCerebral Amyloid AngiopathyNeurosurgical ProceduresIatrogenic DiseasePostoperative ComplicationsHumansMaleFemaleRetrospective StudiesChildChild, PreschoolAdultInfantAdolescentMiddle AgedInfant, NewbornCohort StudiesCadaverYoung AdultAustria

Stichwörter der Autor:innen

Lyoduraamyloid‐betacadaveric dura materiCAAiatrogenic cerebral amyloid angiopathyneurosurgerypediatricretrospective cohort studies

Autor:innen und Institutionen

  • Department of Neurology, Neurocritical Care and Neurorehabilitation, Member of the European Reference Network EpiCARE, Christian Doppler University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria.
  • Neuroscience Institute, Christian Doppler University Hospital Salzburg, Centre for Cognitive Neuroscience Paracelsus Medical University, Salzburg, Austria.
  • Department of Neurosurgery, Christian Doppler University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria.
  • Institute of Neurointervention, Paracelus Medical University, Salzburg, Austria.
  • Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria.
  • Department of Pathology, General University Hospital Salzburg, Salzburg, Austria.

Zitieren

APA

Pikija, S., Toma, A., Radlberger, R., Griessenauer, C. J., Hecker, C., Trinka, E., Ki, P. H., Kraus, T., Weis, S., Wermer, M. J. H., van Etten, E. S., & Kaushik, K. (2025). Iatrogenic Cerebral Amyloid Angiopathy in Patients Treated With Cadaveric Dura Mater During Childhood Neurosurgery: A Retrospective Cohort Study. European Journal of Neurology. https://doi.org/10.1111/ene.70091

Vancouver

Pikija S, Toma A, Radlberger R, Griessenauer CJ, Hecker C, Trinka E, et al. Iatrogenic Cerebral Amyloid Angiopathy in Patients Treated With Cadaveric Dura Mater During Childhood Neurosurgery: A Retrospective Cohort Study. European Journal of Neurology. 2025. doi:10.1111/ene.70091

BibTeX
@article{Pikija2025,
  author = {Pikija, Slaven and Toma, Andreea and Radlberger, Richard and Griessenauer, Christoph J and Hecker, Constantin and Trinka, Eugen and Ki, Park Hyon and Kraus, Theo and Weis, Serge and Wermer, Marieke J H and van Etten, Ellis S and Kaushik, Kanishk},
  title = {Iatrogenic Cerebral Amyloid Angiopathy in Patients Treated With Cadaveric Dura Mater During Childhood Neurosurgery: A Retrospective Cohort Study},
  journal = {European Journal of Neurology},
  year = {2025},
  doi = {10.1111/ene.70091}
}
Kostenlos starten →